Rakuten Investment Management’s Edwards Lifesciences EW Stock Holding History

Rakuten Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-76,626	Closed	-$6.66M	–	529
2025 Q4	$6.66M	Buy	76,626 +67,361	+727%	+$5.53M	0.02%	233
2025 Q3	$581K	Buy	+9,265	New	+$724K	﹤0.01%	545
2025 Q1	$3.82M	Buy	+53,908	New	+$3.86M	0.02%	257
2024 Q3	$2.27M	Buy	34,137 +8,498	+33%	+$617K	0.01%	218
2024 Q2	$2.39M	Buy	25,639 +9,330	+57%	+$826K	0.02%	158
2024 Q1	$1.56M	Buy	16,309 +14,808	+987%	+$1.24M	0.01%	156
2023 Q4	$115K	Buy	+1,501	New	+$104K	﹤0.01%	166

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Rakuten Investment Management's EW Position: Q1 2026 in Review

Rakuten Investment Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 76,626 shares — an estimated $6.66M sold.

Rakuten Investment Management first reported a position in EW in Q4 2023 and held it in 7 quarters. The position peaked at $6.66M in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Rakuten Investment Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
Rakuten Investment Management sold 76,626 Edwards Lifesciences shares in Q1 2026, an estimated $6.66M.
Rakuten Investment Management first reported a position in Edwards Lifesciences in Q4 2023 and held it in 7 quarters.
Rakuten Investment Management's Edwards Lifesciences position peaked at $6.66M in Q4 2025.
1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.